File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL

Conference Paper: Genetic polymorphisms of p73 is associated with the risk of cervical cancer

TitleGenetic polymorphisms of p73 is associated with the risk of cervical cancer
Authors
Issue Date2007
PublisherAmerican Association for Cancer Research
Citation
The 98th Annual Meeting of the American Association for Cancer Research (AACR 2007), Los Angeles, CA., 14-18 April 2007. In Cancer Research, 2007, v. 67 n. 9S, p. 3434 How to Cite?
AbstractThe p73 protein has a structural and functional homology with p53. Although p73 mutations are rare and occur in less than 2% of all cancers, lost of heterozygosity at the p73 locus are more common at various frequencies in different tumors, suggesting an important role of this gene in carcinogenesis. Nineteen single nucleotide polymorphisms were observed in p73 gene, and most of them were deleterious. Two single nucleotide polymorphisms at positions 4 (G→A) and 14 (C→T) in the uncoding region of exon 2 of the p73 gene are thought to affect p73 function by altering gene expression, perhaps by altering the efficiency of translational initiation. These two polymorphisms are in complete linkage disequilibrium with one another. The correlation of the p73 GC/AT polymorphism with cancer risk has been investigated in some cancers and the results were controversial. Functional analysis implies that this common p73 polymorphism may contribute to cancer development and progression. The aim of this study was to investigate the association of the p73 G4C14-to-A4T14 nucleotide polymorphism with the risk of cervical cancer. Totally 504 cervical cancer patients and 716 normal control subjects were recruited for the study. The normal subjects had no history of cancer and were frequency-matched to the cancer subjects on age and residential area. The mean ages of patients and control subjects were 50.5 and 48.2 years, respectively. Genomic DNA was extracted from cancer specimens and control blood samples. p73 genotyping was performed using TaqMan SNP genotyping assay. The genotype distribution of controls was in agreement with Hardy-Weinberg equilibrium (p = 0.584). The genotyping frequencies of this polymorphism were 64.9% (GC/GC), 30.1% (GC/AT) and 5.0% (AT/AT) in patients, and 58.7% (GC/GC), 35.3% (GC/AT) and 6.0% (AT/AT) in controls, and the difference was not statistically significant (p = 0.089). Since the AT/AT variant homozygotes were relatively uncommon, we combined them with GC/ AT heterozygotes for further statistically analysis. The combined variant genotypes (GC/AT + AT/AT) was found significantly higher in controls than in patients (p = 0.032), suggesting that p73 AT variant might be a protective allele against cervical cancer. Compared to the p73 GC homozygotes, AT variant was associated with significantly decreased risk of cervical cancer (adjusted OR = 0.772, 95% CI = 0.609 - 0.978). However, no association of p73 polymorphism was observed with age in patients and controls, with cut-off points of <50 and ≥50 years (p = 1.0 and p = 0.758, respectively), as well as disease stages (p = 0.654) and cancer histological types (p = 0.503). Patients with the AT variant had a trend of better survival than patients with GC genotype (p = 0.068). These results suggested that the p73 polymorphism may have a role in cervical cancer susceptibility. Further studies are needed to elucidate potential functional relevance of the p73 AT variant allele.
Persistent Identifierhttp://hdl.handle.net/10722/113794
ISSN
2015 Impact Factor: 8.556
2015 SCImago Journal Rankings: 5.372

 

DC FieldValueLanguage
dc.contributor.authorLiu, Sen_HK
dc.contributor.authorChan, YKen_HK
dc.contributor.authorLeung, CYen_HK
dc.contributor.authorTsang, PCKen_HK
dc.contributor.authorNgan, HYSen_HK
dc.date.accessioned2010-09-26T04:31:29Z-
dc.date.available2010-09-26T04:31:29Z-
dc.date.issued2007en_HK
dc.identifier.citationThe 98th Annual Meeting of the American Association for Cancer Research (AACR 2007), Los Angeles, CA., 14-18 April 2007. In Cancer Research, 2007, v. 67 n. 9S, p. 3434-
dc.identifier.issn0008-5472-
dc.identifier.urihttp://hdl.handle.net/10722/113794-
dc.description.abstractThe p73 protein has a structural and functional homology with p53. Although p73 mutations are rare and occur in less than 2% of all cancers, lost of heterozygosity at the p73 locus are more common at various frequencies in different tumors, suggesting an important role of this gene in carcinogenesis. Nineteen single nucleotide polymorphisms were observed in p73 gene, and most of them were deleterious. Two single nucleotide polymorphisms at positions 4 (G→A) and 14 (C→T) in the uncoding region of exon 2 of the p73 gene are thought to affect p73 function by altering gene expression, perhaps by altering the efficiency of translational initiation. These two polymorphisms are in complete linkage disequilibrium with one another. The correlation of the p73 GC/AT polymorphism with cancer risk has been investigated in some cancers and the results were controversial. Functional analysis implies that this common p73 polymorphism may contribute to cancer development and progression. The aim of this study was to investigate the association of the p73 G4C14-to-A4T14 nucleotide polymorphism with the risk of cervical cancer. Totally 504 cervical cancer patients and 716 normal control subjects were recruited for the study. The normal subjects had no history of cancer and were frequency-matched to the cancer subjects on age and residential area. The mean ages of patients and control subjects were 50.5 and 48.2 years, respectively. Genomic DNA was extracted from cancer specimens and control blood samples. p73 genotyping was performed using TaqMan SNP genotyping assay. The genotype distribution of controls was in agreement with Hardy-Weinberg equilibrium (p = 0.584). The genotyping frequencies of this polymorphism were 64.9% (GC/GC), 30.1% (GC/AT) and 5.0% (AT/AT) in patients, and 58.7% (GC/GC), 35.3% (GC/AT) and 6.0% (AT/AT) in controls, and the difference was not statistically significant (p = 0.089). Since the AT/AT variant homozygotes were relatively uncommon, we combined them with GC/ AT heterozygotes for further statistically analysis. The combined variant genotypes (GC/AT + AT/AT) was found significantly higher in controls than in patients (p = 0.032), suggesting that p73 AT variant might be a protective allele against cervical cancer. Compared to the p73 GC homozygotes, AT variant was associated with significantly decreased risk of cervical cancer (adjusted OR = 0.772, 95% CI = 0.609 - 0.978). However, no association of p73 polymorphism was observed with age in patients and controls, with cut-off points of <50 and ≥50 years (p = 1.0 and p = 0.758, respectively), as well as disease stages (p = 0.654) and cancer histological types (p = 0.503). Patients with the AT variant had a trend of better survival than patients with GC genotype (p = 0.068). These results suggested that the p73 polymorphism may have a role in cervical cancer susceptibility. Further studies are needed to elucidate potential functional relevance of the p73 AT variant allele.-
dc.languageengen_HK
dc.publisherAmerican Association for Cancer Research-
dc.relation.ispartofCancer Researchen_HK
dc.titleGenetic polymorphisms of p73 is associated with the risk of cervical canceren_HK
dc.typeConference_Paperen_HK
dc.identifier.emailLiu, S: stephasl@HKUCC.hku.hken_HK
dc.identifier.emailChan, YK: kelvinc@pathology.hku.hken_HK
dc.identifier.emailLeung, CY: cyleungr@HKUCC.hku.hken_HK
dc.identifier.emailTsang, PCK: pcktsang@HKUCC.hku.hken_HK
dc.identifier.emailNgan, HYS: hysngan@hkucc.hku.hken_HK
dc.identifier.authorityLiu, S=rp00372en_HK
dc.identifier.authorityChan, YK=rp00453en_HK
dc.identifier.authorityNgan, HYS=rp00346en_HK
dc.identifier.hkuros141192en_HK
dc.identifier.volume67-
dc.identifier.issue9S-
dc.identifier.spage3434-
dc.identifier.epage3434-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats